Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518999 | PMC |
| http://dx.doi.org/10.1007/s00508-020-01694-x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Several key and difficult issues related to the grading of urothelial carcinoma of urinary bladder].
Zhonghua Bing Li Xue Za Zhi
August 2024
Department of Pathology and Laboratory Medicine, Department of Surgery (Urology), Brown University Warren Alpert Medical School, the Legorreta Cancer Center at Brown University, Providence, RI 02903, U S A.
Grading and staging are the most important prognostic factors for both non-invasive and invasive urothelial carcinomas, and are also one of the most common difficulties encountered by pathologists in the daily diagnostic practice of urothelial carcinoma. Recently, the International Society of Urological Pathology organized a survey and questionnaire conference on various issues related to the diagnosis, grading, and staging of urothelial carcinoma, and ultimately formed a series of consensus opinions. This article briefly summarizes the consensus opinions of this series, and combines them with the current pathological diagnosis status of urothelial carcinoma in China.
View Article and Find Full Text PDFExpression of PDL-1 between primary and recurrent/metastatic head and neck squamous cell carcinoma: A bi-institutional retrospective concordance analysis (CONCORDL-1 study).
Oral Oncol
October 2024
Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072 Pieve Emanuele, Milan, Italy.
Introduction: Immune checkpoint inhibitors (ICIs) have demonstrated efficacy in the treatment of recurrent and/or metastatic (RM) head and neck squamous cell carcinoma (HNSCC) Keynote 048 highlighted the relevance of PD-L1 Combined Positive Score (CPS) as a predictive biomarker for ICIs treatment, but challenges persist regarding ideal assessment and concordance between primary and relapsing tumor has not been determined.
Material And Methods: This is a retrospective multicentric study that included HNSCC patients with locoregional and/or metastatic relapses after curative treatment. Histological samples of primary tumors and corresponding relapses were collected.
Immunosuppression in liver transplant oncology: position paper of the Italian Board of Experts in Liver Transplantation (I-BELT).
Updates Surg
June 2024
Department of Surgical, Oncological and Gastroenterological Sciences, General Surgery 2 Hepato-Pancreato-Biliary Surgery and Liver Transplantation, Padua University Hospital, Via Giustiniani 2, 34128, Padua, PD, Italy.
Liver transplant oncology (TO) represents an area of increasing clinical and scientific interest including a heterogeneous group of clinical-pathological settings. Immunosuppressive management after LT is a key factor relevantly impacting result. However, disease-related guidance is still lacking, and many open questions remain in the field.
View Article and Find Full Text PDFClinical-Pathological Conference Series from the Medical University of Graz : Case No 178: A 30-year-old nurse with urine dipstick (+++)‑positive for protein in her late pregnancy.
Wien Klin Wochenschr
May 2024
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, 8036, Graz, Austria.
Protocol on establishing a prospective enhanced surveillance of vaccine preventable diseases in residential aged care facilities in Central Queensland, Australia: an observational study.
BMJ Open
June 2022
Central Queensland Public Health Unit, Central Queensland Hospital and Health Service, Rockhampton, Queensland, Australia
Article Synopsis
- Infectious diseases pose a significant threat to residents of residential aged care facilities (RACFs), highlighting the need for improved surveillance and understanding of vaccine-preventable diseases (VPDs) in these populations.
- This study aims to implement an active enhanced surveillance system in RACFs in Central Queensland to gather data on the burden of VPDs, their causes, risk factors, and effectiveness of vaccines currently provided under the National Immunization Program.
- Ethical approval has been granted for this research, allowing for the collection of non-identifiable data to ensure participant privacy while aiming to inform public health strategies and improve outcomes in vulnerable groups.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!